Predict your next investment

Corporation
HEALTHCARE | Pharmaceuticals / Drugs
jcrpharm.co.jp

See what CB Insights has to offer

Partners & Customers

9

About JCR Pharmaceuticals

JCR Pharmaceuticals is a producer of pharmaceutical products and medical injection devices. It also operates a medical reach and development lab for projects like biopharmaceuticals and stem cell therapy.

JCR Pharmaceuticals Headquarter Location

3-19 Kasuga-cho Ashiya

Hyogo, 659-0021,

Japan

+81 0797328591

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

JCR Pharmaceuticals Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

JCR Pharmaceuticals Rank

Latest JCR Pharmaceuticals News

Takeda secures ex-U.S. rights to JCR Pharma’s Hunter syndrome treatment

Oct 5, 2021

Takeda Pharmaceutical Co. Ltd. and JCR Pharmaceuticals Co. Ltd. have negotiated a geographically-focused licensing deal to develop and commercialize JR-141 (pabinafusp alfa), a potential therapy for mucopolysaccharidosis type II, also known as Hunter syndrome.

JCR Pharmaceuticals Acquisitions

1 Acquisition

JCR Pharmaceuticals acquired 1 company. Their latest acquisition was ArmaGen on March 27, 2020.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

3/27/2020

Series B

$27M

Acquired

2

Date

3/27/2020

Investment Stage

Series B

Companies

Valuation

Total Funding

$27M

Note

Acquired

Sources

2

JCR Pharmaceuticals Partners & Customers

9 Partners and customers

JCR Pharmaceuticals has 9 strategic partners and customers. JCR Pharmaceuticals recently partnered with AstraZeneca on August 8, 2020.

Date

Type

Business Partner

Country

News Snippet

Sources

8/7/2020

Client

AstraZeneca

United Kingdom

AstraZeneca taps JCR Pharmaceuticals, Daiichi Sankyo and other local pharmas to supply COVID-19 shots to Japan

AstraZeneca has tapped both Daiichi Sankyo proper and its Biotech label in the latest supply pact .

1

6/11/2019

Licensor

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

10/24/2018

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

7/18/2017

Licensee

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

12/9/2016

Licensor

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

8/7/2020

6/11/2019

10/24/2018

7/18/2017

12/9/2016

Type

Client

Licensor

Partner

Licensee

Licensor

Business Partner

AstraZeneca

Country

United Kingdom

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

News Snippet

AstraZeneca taps JCR Pharmaceuticals, Daiichi Sankyo and other local pharmas to supply COVID-19 shots to Japan

AstraZeneca has tapped both Daiichi Sankyo proper and its Biotech label in the latest supply pact .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

JCR Pharmaceuticals Team

1 Team Member

JCR Pharmaceuticals has 1 team member, including current Chief Executive Officer, Shin Ashida.

Name

Work History

Title

Status

Shin Ashida

Chief Executive Officer

Current

Name

Shin Ashida

Work History

Title

Chief Executive Officer

Status

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.